MIP PHARMA DANMARK ApS
Credit rating
Company information
About MIP PHARMA DANMARK ApS
MIP PHARMA DANMARK ApS (CVR number: 32886280) is a company from KØBENHAVN. The company recorded a gross profit of -92.4 kDKK in 2023. The operating profit was -92.4 kDKK, while net earnings were -109.1 kDKK. The profitability of the company measured by Return on Assets (ROA) was -17.2 %, which can be considered poor and Return on Equity (ROE) was -363.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -93.6 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. MIP PHARMA DANMARK ApS's liquidity measured by quick ratio was 1 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | -24.00 | -38.54 | -48.21 | -38.67 | -92.38 |
EBIT | -24.00 | -38.54 | -48.21 | -38.67 | -92.38 |
Net earnings | -37.93 | -52.68 | -79.07 | -65.05 | - 109.13 |
Shareholders equity total | - 255.10 | - 307.78 | - 386.85 | - 451.90 | - 561.04 |
Balance sheet total (assets) | 15.93 | 22.01 | 24.60 | 21.64 | 38.36 |
Net debt | 246.85 | 300.39 | 342.98 | 427.03 | 531.54 |
Profitability | |||||
EBIT-% | |||||
ROA | -9.5 % | -12.8 % | -12.7 % | -8.7 % | -17.2 % |
ROE | -226.8 % | -277.7 % | -339.3 % | -281.4 % | -363.8 % |
ROI | -9.8 % | -13.2 % | -13.7 % | -9.5 % | -18.3 % |
Economic value added (EVA) | -12.21 | -24.92 | -31.69 | -17.99 | -68.64 |
Solvency | |||||
Equity ratio | -94.1 % | -93.3 % | -94.0 % | -95.4 % | -93.6 % |
Gearing | -103.0 % | -104.5 % | -95.0 % | -99.0 % | -100.0 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1.9 | 1.0 | 0.3 | 0.8 | 1.0 |
Current ratio | 1.9 | 1.0 | 0.3 | 0.8 | 1.0 |
Cash and cash equivalents | 15.93 | 21.15 | 24.60 | 20.46 | 29.57 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | B | B | B | B | B |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.